Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-438 vs Lansoprazole in Duodenal Ulcer
NCT03050359Phase 3Completed
- Sponsor
- Takeda
- Start
- Apr 2017
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of vonoprazan in duodenal ulcer, Helicobacter pylori infection, sponsored by Takeda. Started Apr 2017; status: completed.
02
Drugs
vonoprazan
03
Conditions
duodenal ulcerHelicobacter pylori infection
Beyond the preview
Go deeper on NCT03050359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03050359.